Intravenous propranolol in patients with inflammation.

Abstract

British Journal of Clinical PharmacologyVolume 13, Issue 4 p. 577-578 Free Access Intravenous propranolol in patients with inflammation. DG Waller, DG WallerSearch for more papers by this authorCL Smith, CL SmithSearch for more papers by this authorAG Renwick, AG RenwickSearch for more papers by this authorCF George, CF GeorgeSearch for more papers by this author DG Waller, DG WallerSearch for more papers by this authorCL Smith, CL SmithSearch for more papers by this authorAG Renwick, AG RenwickSearch for more papers by this authorCF George, CF GeorgeSearch for more papers by this author First published: April 1982 https://doi.org/10.1111/j.1365-2125.1982.tb01426.xCitations: 8AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES De LEVE, L.D. & PIAFSKY, K.M. (1981). Pharmacokinetic consequences of variation in plasma propranolol binding due to rheumatoid arthritis. Clin. Pharmac. Ther., 29, 239– 240. McDEVITT, D.G., FRISK-HOLMBERG, M., HOLLIFIELD, J.W. & SHAND, D.G. (1976). Plasma binding and the affinity of propranolol for the beta receptor in man. Clin. Pharmac. Ther., 20, 152– 157. NATION, R.L., PENG, G.W. & CHIOU, W.L. (1978). High pressure liquid chromatographic method for the simultaneous quantitative analysis of propranolol and 4-hydroxy propranolol in plasma. J. Chromatog., 145, 429– 436. PARSONS, R.L., KAYE, C.M., RAYMOND, K., TROUNCE, J.R. & TURNER, P. (1976). Absorption of propranolol and practolol in coeliac disease. Gut, 17, 139– 143. PIAFSKY, K.M., BORGA, O., ODAR-CEDERLOF, I., JOHANSSON, C. & SJOQVIST, F. (1978). Increased plasma protein binding of propranolol and chlor-promazine mediated by disease-induced elevations of plasma aracid glycoprotein. New Engl. J. Med., 299, 1435– 1439. SCHNEIDER, R.E., BABB, J., BISHOP, H., MITCHARD, M., HOARE, A.M. & HAWKINS, C.F. (1976). Plasma levels of propranolol in treated patients with coeliac disease and patients with Crohn's disease. Br. med. J., 2, 794– 795. SCHNEIDER, R.E., BISHOP, H. & HAWKINS, C.F. (1979). Plasma propranolol concentrations and the erythrocyte sedimentation rate. Br. J. clin. Pharmac., 8, 43– 47. Citing Literature Volume13, Issue4April 1982Pages 577-578 ReferencesRelatedInformation